An in silico approach to develop potential therapies against Middle East Respiratory Syndrome Coronavirus (MERS-CoV)

An in silico approach to develop potential therapies against Middle East Respiratory Syndrome Coronavirus (MERS-CoV)

A deadly respiratory disease Middle East Respiratory Syndrome (MERS) is caused by a perilous virus known as MERS-CoV, which has a severe impact on human health. Currently, there is no approved vaccine, prophylaxis, or antiviral therapeutics for preventing MERS-CoV infection. Due to its inexorable an...

Full description

Bibliographic Details
Main Authors: Suvro Biswas, Mohasana Akter Mita, Shamima Afrose, Md. Robiul Hasan, Mst. Sharmin Sultana Shimu, Shahriar Zaman, Md. Abu Saleh
Format: Article
Language:English
Published: Elsevier 2024-02-01
Series:Heliyon
Subjects:
Phytoconstituents
MERS-CoV
3CLpro
Molecular docking
ADMET
Molecular dynamics simulation
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844024018681

Internet

http://www.sciencedirect.com/science/article/pii/S2405844024018681

Similar Items